Tim M. Mayleben

2018 - Esperion Therapeutics

In 2018, Tim M. Mayleben earned a total compensation of $9.7M as President and Chief Executive Officer at Esperion Therapeutics, a 94% increase compared to previous year.

Compensation breakdown

Bonus$115,000
Non-Equity Incentive Plan$360,000
Option Awards$8,568,224
Salary$600,000
Other$81,615
Total$9,724,839

Mayleben received $8.6M in option awards, accounting for 88% of the total pay in 2018.

Mayleben also received $115K in bonus, $360K in non-equity incentive plan, $600K in salary and $81.6K in other compensation.

Rankings

In 2018, Tim M. Mayleben's compensation ranked 726th out of 14,244 executives tracked by ExecPay. In other words, Mayleben earned more than 94.9% of executives.

ClassificationRankingPercentile
All
726
out of 14,244
95th
Division
Manufacturing
237
out of 5,759
96th
Major group
Chemicals And Allied Products
67
out of 2,122
97th
Industry group
Drugs
51
out of 1,811
97th
Industry
Pharmaceutical Preparations
36
out of 1,385
97th

Pay ratio

Tim M. Mayleben's Pay$9,724,839
Median Employee's Pay$601,814
Pay Ratio

16

to 1

In 2018, the annual total compensation of Tim M. Mayleben was $9,724,839.

The annual total compensation of the median employee at Esperion Therapeutics was $601,814.

The ratio of Tim M. Mayleben's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on April 18, 2019.

Mayleben's colleagues

We found three more compensation records of executives who worked with Tim M. Mayleben at Esperion Therapeutics in 2018.

2018

Mark Glickman

Esperion Therapeutics

Chief Commercial Officer

2018

Richard Bartram

Esperion Therapeutics

Chief Financial Officer

2018

Narendra DABT

Esperion Therapeutics

Executive Vice President, Research and Development

News

In-depth

You may also like